Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients.
Abstract
Oxidative stress plays the most important role in the pathogenesis of stroke. Extremely low frequency electromagnetic field (ELF-EMF) therapy may be complementary in post-stroke therapy, as it modulates oxidative stress. The aim of this study was to evaluate the messenger ribonucleic acid (mRNA) levels of certain antioxidant genes in post-stroke patients given ELF-EMF therapy. Forty-eight post-stroke patients were divided into two groups: an ELF-EMF group and a non-ELF-EMF group. All patients underwent the same program of physical therapy, but the ELF-EMF group was additionally given ELF-EMF treatment. In order to determine the level of gene expression, we evaluated the level of mRNA expression of catalase, superoxide dismutase, and glutathione peroxidase. We observed that after ELF-EMF therapy, the mRNA expression of the studied genes (CAT, SOD1, SOD2, GPx1, and GPx4) significantly increased, which enhanced the antioxidant defence of the body. ELF-EMF therapy intensifies the endogenous antioxidant system by increasing the mRNA expression of genes encoding antioxidant enzymes and enhances the effectiveness of post-stroke patient therapy.
AI evidence extraction
Main findings
In 48 post-stroke patients, those receiving additional ELF-EMF therapy showed a significant increase in mRNA expression of CAT, SOD1, SOD2, GPx1, and GPx4 after therapy, compared with the non-ELF-EMF group. The authors interpret this as enhanced antioxidant defence and improved effectiveness of post-stroke therapy.
Outcomes measured
- mRNA expression of antioxidant enzyme genes (CAT, SOD1, SOD2, GPx1, GPx4)
- Antioxidant defence/endogenous antioxidant system (as inferred from gene expression changes)
Limitations
- No ELF-EMF exposure parameters reported (e.g., frequency, intensity, session duration).
- Study design details not provided in abstract (e.g., randomization, blinding, allocation method).
- Clinical outcomes are not described; outcomes reported are gene expression measures.
Suggested hubs
-
occupational-exposure
(0.05) ELF-EMF is studied, but this appears to be therapeutic exposure rather than occupational; hub match is weak.
View raw extracted JSON
{
"study_type": "other",
"exposure": {
"band": "ELF",
"source": "therapy",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Post-stroke patients",
"sample_size": 48,
"outcomes": [
"mRNA expression of antioxidant enzyme genes (CAT, SOD1, SOD2, GPx1, GPx4)",
"Antioxidant defence/endogenous antioxidant system (as inferred from gene expression changes)"
],
"main_findings": "In 48 post-stroke patients, those receiving additional ELF-EMF therapy showed a significant increase in mRNA expression of CAT, SOD1, SOD2, GPx1, and GPx4 after therapy, compared with the non-ELF-EMF group. The authors interpret this as enhanced antioxidant defence and improved effectiveness of post-stroke therapy.",
"effect_direction": "benefit",
"limitations": [
"No ELF-EMF exposure parameters reported (e.g., frequency, intensity, session duration).",
"Study design details not provided in abstract (e.g., randomization, blinding, allocation method).",
"Clinical outcomes are not described; outcomes reported are gene expression measures."
],
"evidence_strength": "low",
"confidence": 0.7399999999999999911182158029987476766109466552734375,
"peer_reviewed_likely": "yes",
"keywords": [
"extremely low frequency electromagnetic field",
"ELF-EMF",
"stroke",
"post-stroke therapy",
"oxidative stress",
"antioxidant enzymes",
"gene expression",
"catalase",
"superoxide dismutase",
"glutathione peroxidase",
"mRNA"
],
"suggested_hubs": [
{
"slug": "occupational-exposure",
"weight": 0.05000000000000000277555756156289135105907917022705078125,
"reason": "ELF-EMF is studied, but this appears to be therapeutic exposure rather than occupational; hub match is weak."
}
]
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.